Skip to content

FM FIRST CHINA FUNDS

First Manhattan Co. serves as the investment advisor to two private funds that invest in mainland China-focused, publicly-traded companies (the “Funds”).

Supported by the resources and operational infrastructure of First Manhattan, First Beijing Investment Limited, a Hong-Kong company, serves as the sub-subadvisor to the Funds, and First Jingguang Consulting (Shenzen) Co. Ltd., a mainland Chinese company, provides research services to the Funds’ advisors.

Xiang “Sean” Huang, Portfolio Manager of the Funds, leads the advisory and research efforts of First Beijing and First Jingguang, respectively. He is supported by a local team of analysts and associates who are located in Shenzhen, Beijing, Shanghai, and Hong Kong. Adam Schwartz, a Senior Managing Director at First Manhattan, is co-Portfolio Manager of the Funds.

FM First China Funds

Leveraging First Manhattan’s research-intensive investment philosophy, the team employs a long term, bottom up, value-oriented approach to identify undervalued and misunderstood companies that either derive a majority of their assets from, or maintain a majority of their assets in, mainland China.

For more information about the FM First China Funds and to determine if you are eligible to invest in them, please contact Adam at 212.756.3388.

Learn more about the FM First China Funds.

Learn More

FIRST MANHATTAN HEALTH CARE FUNDS

First Manhattan Co. serves as the investment advisor to First BioMed, a private fund that invests in companies primarily engaged in the biomedical and biotechnology sectors.

In addition, First Manhattan serves as the investment advisor to and general partner of First Health, a private fund that invests in publicly-traded companies in the health care and related sectors.

Sam Colin, M.D., a Senior Managing Director at First Manhattan, has been the Portfolio Manager of First Health and First BioMed since their inceptions in 1998 and 2002, respectively.

Supported by a team of analysts, Sam leverages First Manhattan’s investment approach – rooted in deep, independent research – to uncover undervalued companies in biotechnology and health care.

For more information about the First Manhattan Health Care Funds and to determine if you meet the Funds’ eligibility requirements, please contact Sam at 212.756.3244.

FMZ VENTURES FUND, L.P.

FMZ Ventures Fund, L.P., a collaboration between First Manhattan and Michael Zeisser, is a private fund that seeks to generate long-term capital appreciation by making highly selective private growth/venture investments in the Experience Economy and in digitally-enabled consumer marketplace companies.

Leveraging First Manhattan's value-oriented investment philosophy, the team conducts deep analytic due diligence on all aspects of a company and its market. The fund's management team consists of Michael, Adam Schwartz, and Jordan Monahan.

For more information about the fund and to determine if you meet its eligibility requirements, please contact Adam at 212.756.3388.

Explore Our Services

Separately Managed Portfolios

You are at the center of the investment process. Our long-term investment approach has been time-tested over multiple decades and has delivered value-added results.

Learn More

Wealth Planning

We can partner with you to develop a 360-degree view of your financial picture and goals, and assist you with a wide variety of wealth planning matters.

Learn More